ABCG2 and non-small cell lung carcinoma: In three studies of advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy, expression of ABCG2 was not associated with ORR or PFS in two (64, 65), while in one study, ABCG2 expression was associated with short PFS and a numerically lower ORR (66).